SCHEMBL7415041

SCHEMBL7415041

N=C(N)NOCCCOc1ccc(C[C@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])C(=O)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
ITGB3 P05106 6/20 0.38
ITGA2B P08514 6/20 0.38
F2 P00734 3/20 0.37
TMPRSS6 Q8IU80 2/20 0.37
KDM4A O75164 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 1/20 0.35
BCL2 P10415 4/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7415034 0.90 ITGB3 (0.47) ARITGB3ITGA2BF2TMPRSS6
SCHEMBL7414101 0.90 ITGB3 (0.40) ITGB3ITGA2BF2TMPRSS6POLB
SCHEMBL7418356 0.89 ITGB3 (0.41) ITGB3ITGA2BF2TMPRSS6KDM4A
SCHEMBL7414402 0.87 POLB (0.49) ITGB3ITGA2BF2TMPRSS6MEN1
SCHEMBL7415119 0.87 ITGB1 (0.39) ITGB3ITGA2BF2TMPRSS6PPARG
SCHEMBL7413080 0.87 MMP7 (0.40) ITGB3ITGA2BF2TMPRSS6PPARG
SCHEMBL7415446 0.87 ITGB3 (0.39) ITGB3ITGA2BF2TMPRSS6PPARG
SCHEMBL7698475 0.87 ITGB3 (0.50) ARITGB3ITGA2BKDM4APPARG
SCHEMBL7694227 0.87 F10 (0.41) ITGB3ITGA2BF2TMPRSS6
SCHEMBL7414953 0.87 ITGB3 (0.43) ITGB3ITGA2BF2TMPRSS6PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed